Ocuphire CEO says her post was terminated with no cause given
Ocuphire Pharma, which is awaiting its first FDA approval decision in September, announced that Mina Sooch will no longer be president and CEO.
No reason …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
